ZBHZimmer Biomet
Price
-10%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, undemanding price, growth steady, the market undecided.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (“CMFT”) products; bone cement; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Zimmer Biomet (ZBH) reported revenue of $2.18B in Q2 2026 (quarter ended Jun 30, 2026), up 4.8% from the same quarter a year earlier. That came with a gross margin of 71% and net income of $198M (9.1% of revenue). For the full year FY2025, revenue was $8.23B (+7.2% year on year) and net income $705M. Its largest product in Q2 2026 was Knees at $829M, 38% of the disclosed total, ahead of SET at 27%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 8, 2026On September 8, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) notified Kevin Thornal, Group President, Global Businesses and the Americas, that his position is being restructured.Director or officer change · Form 8-K
- Aug 5, 2026In the quarter ended March 31, 2026, the responsibilities of certain senior leaders who report to our chief operating decision maker (“CODM”) and the related operating profit information that these leaders present to the CODM changed.Other event · Form 8-K
- Aug 5, 2026Second Quarter 2026 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $2.18BThe company’s own SEC segment disclosure.
- Knees$828.9M38%
- SET$586.0M27%
- Hips$562.7M26%
- Technology And Data Bone Cement And Surgical$199.4M9%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
The closest names by size in the same industry